1. Salen-based bifunctional chemosensor for copper (II) ions: Inhibition of copper-induced amyloid-β aggregation
- Author
-
Gui-Juan Cheng, Ming Sun, Chongzhao Ran, Lin Yu, Yu Zhou, Wei Zhao, Hui-juan Yu, Lu Wang, and Steven H. Liang
- Subjects
Amyloid β ,Drug Evaluation, Preclinical ,chemistry.chemical_element ,02 engineering and technology ,Protein Aggregation, Pathological ,01 natural sciences ,Biochemistry ,Analytical Chemistry ,Ion ,Copper homeostasis ,Protein Aggregates ,chemistry.chemical_compound ,Cell Line, Tumor ,Humans ,Environmental Chemistry ,Bifunctional ,Spectroscopy ,Ions ,Amyloid beta-Peptides ,Aqueous solution ,010401 analytical chemistry ,Hydrogen-Ion Concentration ,Ethylenediamines ,021001 nanoscience & nanotechnology ,Combinatorial chemistry ,Copper ,0104 chemical sciences ,chemistry ,Salen ligand ,0210 nano-technology ,Menkes' syndrome - Abstract
Disruption of copper homeostasis is associated with a number of severe diseases including Alzheimer’s disease (AD), Parkinson’s disease (PD), Wilson’s disease, and Menkes syndrome. Given this association, the detection and capture of Cu2+ in biological fluids and tissues may provide a new direction for the diagnosis and treatment of related disorders. The current analytical approaches, however, are challenging due to the high cost, complexity, and long time required to prepare and analyze samples. Here, we report a novel salen ligand, namely N,N’-(1,2-phenylene)bis(1-(1H-imidazol-4-yl)methanimine) (pimi), which can readily detect and concurrently capture Cu2+ from aqueous as well as biological mediums. Pimi can selectively and specifically detect Cu2+ from biofluid and cellular samples with rapid ccresponse time (
- Published
- 2020